Novalis Biotech

Ottergemsesteenweg Zuid 808 Bus B511

9000 Gent

BE

Novalis Biotech

Foundation date

21/08/2017

Sector

#Investor

Subsector

Novalis Biotech seeds biotechnology and life sciences related companies. Novalis develops innovative investment ideas at the early stage and supports further evolution of the companies, by a combination of our contacts, experience and complementary skills.

Our investment ideas focus on the interaction between bio-informatics and life sciences. We strongly believe in applying innovative information technology to advance prevention, diagnosis, or treatment of disease.

Novalis was founded by Prof. Wim Van Criekinge and Jan Van den Berghe.

As an early stage private equity/venture capital fund, we are a dynamic and flexible player not restricting ourselves to specific fields of expertise, but open to discuss any proposition in the field of life-sciences.

Upcoming events

Latest news

  • HERAN Partners co-leads the GBP 6,5m financing round of Hypervision Surgical to support the further development and commercial roll-out of their Hyperspectral Imaging platform

    Tuesday June 6th 2023

  • ANeuroTech receives IND approval from the FDA for pivotal Phase IIIB trial of adjunctive anti-depression drug, ANT-01

    Monday June 5th 2023

  • Biotalys continues to demonstrate strength of first biocontrol in latest global field trials

    Friday June 2nd 2023